Madrigal Pharmaceuticals (MDGL) News Today $292.76 +2.04 (+0.70%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MDGL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Tema Etfs LLC Makes New Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Tema Etfs LLC bought a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 3,620 shares of the biopharmaceutical company's stock, valued at approximMay 20 at 6:16 AM | marketbeat.comRafferty Asset Management LLC Lowers Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Rafferty Asset Management LLC lessened its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 25.8% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 33,123 shares of the biopharmaceutical company's stock afterMay 19 at 6:13 AM | marketbeat.comBNP Paribas Financial Markets Sells 2,846 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)BNP Paribas Financial Markets decreased its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 29.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,921 shares of thMay 19 at 3:39 AM | marketbeat.comDeutsche Bank AG Sells 5,284 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Deutsche Bank AG lowered its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 10.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,658 shares of the biopharmaceutical company's stoMay 18 at 4:07 AM | marketbeat.comIn Search Of A Tailwind, Sailing The Doldrums With Madrigal PharmaceuticalsMay 17, 2025 | seekingalpha.comPolar Capital Holdings Plc Has $42.50 Million Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Polar Capital Holdings Plc lifted its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 37.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 137,720 shaMay 17, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Position Increased by Ensign Peak Advisors IncEnsign Peak Advisors Inc lifted its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 124.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 35,361 shares of the biopharmaceutical company's stock after buying an addiMay 15, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Bought by Bank of America Corp DEBank of America Corp DE raised its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 1.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 217,828 shares of the biopharmaceutical company's stockMay 15, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Sold by Janus Henderson Group PLCJanus Henderson Group PLC lessened its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 10.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,208,394 shares of the biopharmaceutical company'sMay 13, 2025 | marketbeat.comFORA Capital LLC Takes $347,000 Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)FORA Capital LLC purchased a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,123 shares of the biopharmaceutical company's stockMay 13, 2025 | marketbeat.comBrevan Howard Capital Management LP Acquires New Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Brevan Howard Capital Management LP purchased a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,001 shares of the biopharmaceuMay 13, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Recommendation of "Moderate Buy" by AnalystsMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the ten research firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and nine have iMay 13, 2025 | marketbeat.comMadrigal Pharmaceuticals Reports Promising Two-Year Data for Rezdiffra in MASH CirrhosisMay 12, 2025 | msn.comMadrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH CirrhosisMay 10, 2025 | globenewswire.comBridgefront Capital LLC Purchases New Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Bridgefront Capital LLC acquired a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,084 shares of the biopharmaceutical companMay 10, 2025 | marketbeat.comAlgert Global LLC Buys New Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Algert Global LLC purchased a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 9,770 shares of the biopharMay 10, 2025 | marketbeat.comNorthern Trust Corp Raises Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Northern Trust Corp grew its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 5.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 155,883 shares of the biopharmaceutical company'sMay 10, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (MDGL): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside PotentialMay 10, 2025 | finance.yahoo.comFirst Trust Advisors LP Acquires 1,352 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)First Trust Advisors LP raised its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 50.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,014 shares of the biopharmaceutical company's stock after purchasing an additiMay 10, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Sells 5,877 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)The Manufacturers Life Insurance Company cut its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 19.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,080 shares ofMay 9, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (MDGL): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside PotentialMay 9, 2025 | insidermonkey.comBayesian Capital Management LP Boosts Stock Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Bayesian Capital Management LP grew its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 137.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,573 shares oMay 8, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Has $1.71 Million Stock Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Schonfeld Strategic Advisors LLC decreased its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 88.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 5,525 shares of the biopharmaceutical company's stock after sellingMay 8, 2025 | marketbeat.comMadrigal Pharmaceuticals (MDGL): Among Billionaire John Paulson’s Stocks with Huge Upside PotentialMay 7, 2025 | insidermonkey.comWhat is B. Riley's Estimate for MDGL FY2028 Earnings?Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) - Research analysts at B. Riley issued their FY2028 earnings per share (EPS) estimates for Madrigal Pharmaceuticals in a research note issued on Thursday, May 1st. B. Riley analyst M. Mamtani expects that the biopharmaceutical company wilMay 7, 2025 | marketbeat.comMadrigal Pharmaceuticals: An Encouraging Start For RezdiffraMay 6, 2025 | seekingalpha.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Posts Quarterly Earnings Results, Beats Expectations By $0.30 EPSMadrigal Pharmaceuticals (NASDAQ:MDGL - Get Free Report) announced its earnings results on Thursday. The biopharmaceutical company reported ($3.32) earnings per share for the quarter, beating analysts' consensus estimates of ($3.62) by $0.30. The company had revenue of $137.25 million for the quarter, compared to analysts' expectations of $112.79 million. During the same quarter in the prior year, the firm posted ($7.38) earnings per share.May 5, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Bought by ArrowMark Colorado Holdings LLCArrowMark Colorado Holdings LLC increased its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 23.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 199,667 shares of the biopharmaMay 5, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Shares Down 4.4% - What's Next?Madrigal Pharmaceuticals (NASDAQ:MDGL) Trading Down 4.4% - Time to Sell?May 5, 2025 | marketbeat.comVoya Investment Management LLC Sells 33,672 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Voya Investment Management LLC cut its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 77.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,942 shares of the biopharmaceuticaMay 5, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Sold by Mariner LLCMariner LLC lowered its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 41.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,746 shares of the biopharmaceutical comMay 4, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (MDGL) Q1 2025 Earnings Call TranscriptMay 3, 2025 | seekingalpha.comMadrigal Pharmaceuticals Inc (MDGL) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...May 3, 2025 | finance.yahoo.comCANADA LIFE ASSURANCE Co Buys 1,045 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)CANADA LIFE ASSURANCE Co increased its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 81.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,334 shares ofMay 2, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 1, 2025 | seekingalpha.comMadrigal Pharmaceuticals to Present Breakthrough Resmetirom Data at EASL Congress 2025May 1, 2025 | msn.comMadrigal Pharmaceuticals (MDGL) Projected to Post Earnings on TuesdayMadrigal Pharmaceuticals (NASDAQ:MDGL) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-madrigal-pharmaceuticals-inc-stock/)May 1, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Has $5.76 Million Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Emerald Mutual Fund Advisers Trust lessened its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 14.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownMay 1, 2025 | marketbeat.comMadrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate UpdatesMay 1, 2025 | globenewswire.comAdage Capital Partners GP L.L.C. Invests $6.16 Million in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Adage Capital Partners GP L.L.C. purchased a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 19,960 shares of the biopharmaceutMay 1, 2025 | marketbeat.comMadrigal stock holds neutral as 1Q revenue beats estimatesApril 30, 2025 | investing.comUncovering Potential: Madrigal Pharmaceuticals's Earnings PreviewApril 30, 2025 | benzinga.comMadrigal Pharmaceuticals, Inc. Q1 2025 Earnings PreviewApril 30, 2025 | msn.comAquatic Capital Management LLC Takes Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Aquatic Capital Management LLC acquired a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 15,032 shares of the biopharmaceutical compApril 30, 2025 | marketbeat.comDark Forest Capital Management LP Takes $397,000 Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Dark Forest Capital Management LP purchased a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,286 shares of the biopharmaceutical company's stock, valuedApril 30, 2025 | marketbeat.comMadrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL CongressApril 29, 2025 | globenewswire.comTri Locum Partners LP Increases Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Tri Locum Partners LP boosted its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 9.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 47,472 shares of the biopharmaceutical company's stock after buApril 29, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Sold by Gilder Gagnon Howe & Co. LLCGilder Gagnon Howe & Co. LLC reduced its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 5.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,168 shares of the biophaApril 29, 2025 | marketbeat.comLord Abbett & CO. LLC Takes Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)Lord Abbett & CO. LLC bought a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 48,917 shares of the biopharmaceutical company's stock, valuedApril 29, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Sold by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD decreased its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 19.8% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 588,764 shares of the biopharmaceutical company's stock after selliApril 29, 2025 | marketbeat.com Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address MDGL Media Mentions By Week MDGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDGL News Sentiment▼1.620.65▲Average Medical News Sentiment MDGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDGL Articles This Week▼88▲MDGL Articles Average Week Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News Today United Therapeutics News Today Incyte News Today Exelixis News Today Neurocrine Biosciences News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Repligen News Today Halozyme Therapeutics News Today Ionis Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDGL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDGL Stock Free MDGL Stock Alerts